217 related articles for article (PubMed ID: 15837155)
1. The use of systemic immune moderators in dermatology: an update.
Kazlow Stern D; Tripp JM; Ho VC; Lebwohl M
Dermatol Clin; 2005 Apr; 23(2):259-300. PubMed ID: 15837155
[TBL] [Abstract][Full Text] [Related]
2. Off-label uses of biologic agents in dermatology: a 2006 update.
Kerns MJ; Graves JE; Smith DI; Heffernan MP
Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive agents in dermatology.
Ho VC; Zloty DM
Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
[TBL] [Abstract][Full Text] [Related]
4. Renal transplantation, immunosuppression and the skin: an update.
Moloney FJ; de Freitas D; Conlon PJ; Murphy GM
Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive therapy of inflammatory diseases of the large intestine].
Rumiantsev VG; Rogozina VA; Osina VA
Eksp Klin Gastroenterol; 2004; (6):89-98, 165. PubMed ID: 16259448
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine in dermatology: the past, the present, and the future.
Patel AA; Swerlick RA; McCall CO
J Am Acad Dermatol; 2006 Sep; 55(3):369-89. PubMed ID: 16908341
[TBL] [Abstract][Full Text] [Related]
7. Advances in immunosuppressive therapy.
Marder W; McCune WJ
Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive drugs in clinical medicine.
ten Berge RJ; Schellekens PT
Neth J Med; 1994 Dec; 45(6):329-38. PubMed ID: 7838250
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive agents in dermatology. An update.
Dutz JP; Ho VC
Dermatol Clin; 1998 Apr; 16(2):235-51. PubMed ID: 9589197
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and tacrolimus in dermatology.
Cather JC; Abramovits W; Menter A
Dermatol Clin; 2001 Jan; 19(1):119-37, ix. PubMed ID: 11155577
[TBL] [Abstract][Full Text] [Related]
11. [The biological treatments for moderate to severe plaque psoriasis].
Thielen AM; Marazza G
Rev Med Suisse; 2008 Apr; 4(155):1089-90, 1092-4. PubMed ID: 18610721
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive drugs in dermatology--benefits and threats.
Kowal A; Warmińska J; Krasowska D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):14-21. PubMed ID: 15323159
[TBL] [Abstract][Full Text] [Related]
13. [Modern dermatologic treatments: a few comments].
Meynadier J
Ann Dermatol Venereol; 1997; 124(8):516-7. PubMed ID: 9740841
[No Abstract] [Full Text] [Related]
14. The use of cyclosporine in dermatology: part I.
Amor KT; Ryan C; Menter A
J Am Acad Dermatol; 2010 Dec; 63(6):925-46; quiz 947-8. PubMed ID: 21093659
[TBL] [Abstract][Full Text] [Related]
15. Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists.
Goyal A; Goyal K; Merola JF
Am J Clin Dermatol; 2015 Jun; 16(3):179-95. PubMed ID: 25854805
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of action of some immunosuppressive drugs].
Liberman AC; Druker J; Refojo D; Arzt E
Medicina (B Aires); 2008; 68(6):455-64. PubMed ID: 19147430
[TBL] [Abstract][Full Text] [Related]
17. [The role of biological agents in dermatology].
Huryń A; Bielecka-Grzela S; Klimowicz A; Zejmo M
Ann Acad Med Stetin; 2007; 53(2):8-13; discussion 13. PubMed ID: 18557371
[TBL] [Abstract][Full Text] [Related]
18. Topical immunomodulators in dermatology.
Khandpur S; Sharma VK; Sumanth K
J Postgrad Med; 2004; 50(2):131-9. PubMed ID: 15235214
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid-sparing agents: conventional systemic immunosuppressants.
Kruh J; Foster CS
Dev Ophthalmol; 2012; 51():29-46. PubMed ID: 22517202
[TBL] [Abstract][Full Text] [Related]
20. Developments in systemic immunomodulatory therapy for psoriasis.
Berger EM; Gottlieb AB
Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
